Document is current

Any future updates will be listed below

Correction: Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study

Crossref DOI link: https://doi.org/10.1007/s00415-025-13494-2

Published Online: 2025-11-18

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark